Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Veracyte
MedTech
JPM24: Veracyte inks $95M deal to buy C2i Genomics
With an eye toward expanding the reach of its cancer diagnostics portfolio, Veracyte has made moves to pick up C2i Genomics.
Andrea Park
Jan 9, 2024 10:22am
Study validates Veracyte’s test for prostate cancer aggression
Feb 15, 2022 12:03pm
Veracyte begins limited release of nasal swab lung cancer test
Oct 11, 2021 11:14am
Veracyte prints new prostate cancer test data after Decipher buy
Jun 14, 2021 12:10pm
Veracyte lays out €260M for French cancer test maker HalioDx
Jun 2, 2021 9:55am
ASCO: Veracyte sets nasal swab lung cancer test for 2021 launch
May 19, 2021 5:30pm
